TipRanks
Go Ultimate55% OFF

Compare Immutep (YP1) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:YP1ImmutepEUR 2.88EUR 21.20M-0.39-91.06%Moderate BuyUnlock the DE:YP1 analyst price target with TipRanks PremiumDE:YP1Unlock the DE:YP1 top-analyst price target with TipRanks Premium
CLLSCellectis SA$1.11$83.96M-1.68-70.00%NeutralUnlock the CLLS analyst price target with TipRanks PremiumDE:YP1 vs CLLSUnlock the CLLS top-analyst price target with TipRanks Premium
RNACCartesian Therapeutics$6.20$196.36M-1.07-22.40%Strong BuyUnlock the RNAC analyst price target with TipRanks PremiumDE:YP1 vs RNACUnlock the RNAC top-analyst price target with TipRanks Premium
SLNSilence Therapeutics$19.77$1.23B-5.19175.98%NeutralUnlock the SLN analyst price target with TipRanks PremiumDE:YP1 vs SLNUnlock the SLN top-analyst price target with TipRanks Premium
LYELLyell Immunopharma$10.84$270.54M-0.68-34.69%Moderate BuyUnlock the LYEL analyst price target with TipRanks PremiumDE:YP1 vs LYELUnlock the LYEL top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:YP1Immutep2.88-28.92-90.94%
CLLSCellectis SA1.03-2.24-68.35%
RNACCartesian Therapeutics6.34-1.79-22.02%
SLNSilence Therapeutics19.7613.15198.94%
LYELLyell Immunopharma10.88-5.67-34.26%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts